ALS News Today’s forums moderator, Amanda Sifford, discusses How Health Canda is Reviewing AMX0035 as a Treatment for ALS, While the U.S. Food and Drug Administration requested data from an additional controlled clinical trial — the PHOENIX trial — before considering AMX0035 for approval.  

Are you interested in learning more about ALS? If so, please visit https://alsnewstoday.com/

Health Canada to Review AMX0035 as ALS Treatment

Forums Director Kevin Schaefer writes about a new at-home exercise routine he’s developed, using his electric ceiling lift.

SMA News Today’s multimedia associate, Price Wooldridge, discusses the first patient treated in the Phase 2/3 trial, assessing higher doses of Spinraza.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

First Patient Treated in The Phase 2/3 Trial, Assessing Higher Doses of Spinraza

ALS News Today is a daily digital news journal that seeks to give ALS patients and their support systems access to the latest science and research news pertaining to the disease. While there is a great deal of research and development underway for treating ALS, very little news is reported in the health media. ALS News Today seeks to fulfill the unmet need in health reporting by levering our talented group of researchers and journalists to source the latest ALS-related news and present it in a format that patients can easily understand.

Health Canada to Review AMX0035 as ALS Treatment

ALS News Today

Related tracks